TriSalus Life Sciences, Inc.
TLSI- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001826667
No open-market purchases or sales by TriSalus Life Sciences, Inc. insiders were filed in the last 90 days; 78 institutions reported holding it in 13F filings for Q2 2026, worth $99.0M in total; no superinvestor holds it.
Other share classesTLSIW
Q4 2023 vs. Q3 2023
How the institutions holding TriSalus Life Sciences, Inc. changed between Q3 2023 and Q4 2023.
All holders in Q4 2023All holders in Q3 2023
| Measure | Q3 2023 | Q4 2023 | Change |
|---|---|---|---|
| Holders | 9 | 19 | +10 |
| Shares | 136.6K | 679.6K | +543.0K (+397.6%) |
| Value | $699.3K | $5.74M | +$5.04M (+721.1%) |
New holders (11)
Institutions that held TriSalus Life Sciences, Inc. at the end of Q4 2023 but not at the end of Q3 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Vanguard Group Inc | 165,136 | $1.40M | 0.00% |
| HC Advisors, LLC | 101,736 | $859.7K | 0.48% |
| HRT Financial LP | 48,011 | $405.0K | 0.00% |
| Wetherby Asset Management Inc | 34,950 | $295.3K | 0.02% |
| Tyche Wealth Partners LLC | 26,664 | $225.3K | 0.05% |
| Northern Trust Corp | 18,190 | $153.7K | 0.00% |
| Creative Planning | 16,216 | $137.0K | 0.00% |
| Cambridge Investment Research Advisors, Inc. | 15,554 | $131.0K | 0.00% |
| Tower Research Capital LLC (TRC) | 1,973 | $16.7K | 0.00% |
| BlackRock Inc. | 1,270 | $10.7K | 0.00% |
| Hoertkorn Richard Charles | 668 | $5.64K | 0.00% |
Sold out (1)
Institutions that held TriSalus Life Sciences, Inc. at the end of Q3 2023 and filed for Q4 2023 without it.
| Institution | Shares, Q3 2023 | Value, Q3 2023 |
|---|---|---|
| Wolverine Asset Management LLC | 415 | $2.12K |